Acumen Pharmaceuticals Ownership | Who Owns Acumen Pharmaceuticals?
Acumen Pharmaceuticals Ownership Summary
Acumen Pharmaceuticals is owned by 62.09% institutional investors, 11.46% insiders, and 26.45% retail investors. Ra capital management is the largest institutional shareholder, holding 24.65% of ABOS shares. Franklin Biotechnology Discv A(acc)USD is the top mutual fund, with 2.44% of its assets in Acumen Pharmaceuticals shares.
ABOS Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Acumen Pharmaceuticals | 62.09% | 11.46% | 26.45% |
| Sector | Healthcare Stocks | 487.91% | 11.08% | -398.99% |
| Industry | Biotech Stocks | 307.10% | 11.11% | -218.21% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Ra capital management | 14.93M | 24.65% | $17.32M |
| Sands capital ventures | 3.42M | 5.64% | $3.96M |
| Franklin resources | 3.27M | 5.45% | $5.63M |
| Blackrock | 2.16M | 3.61% | $5.22M |
| Fmr | 2.02M | 3.37% | $3.48M |
| Vanguard group | 1.94M | 3.23% | $3.34M |
| Knollwood investment advisory | 1.63M | 2.69% | $1.89M |
| Millennium management | 1.14M | 1.88% | $1.25M |
| Jpmorgan chase | 937.91K | 1.56% | $1.61M |
| Alyeska investment group | 939.60K | 1.55% | $1.09M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Sands capital ventures | 3.42M | 0.78% | $3.96M |
| Ra capital management | 14.93M | 0.29% | $17.32M |
| Knollwood investment advisory | 1.63M | 0.18% | $1.89M |
| Adar1 capital management | 916.18K | 0.16% | $1.06M |
| Ikarian capital | 265.77K | 0.06% | $308.29K |
| Laurion capital management lp | 867.05K | 0.02% | $1.01M |
| Intrepid financial planning group | 30.15K | 0.01% | $34.97K |
| Catalyst financial partners | 89.70K | 0.01% | $104.05K |
| Y-intercept (hong kong) | 250.85K | 0.01% | $290.98K |
| Clune & associates | 16.50K | 0.01% | $28.21K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Blackrock | 2.16M | 0.00% | 1.97M |
| Jpmorgan chase | 937.91K | 0.00% | 874.84K |
| Adar1 capital management | 916.18K | 0.16% | 770.00K |
| Sg americas securities | 403.88K | 0.00% | 403.88K |
| Y-intercept (hong kong) | 250.85K | 0.01% | 250.85K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Blackrock funding, inc. /de | 291.96K | - | -2.04M |
| Rock springs capital management lp | - | - | -1.84M |
| Parkman healthcare partners | - | - | -576.66K |
| Franklin resources | 3.27M | 0.00% | -275.44K |
| Tang capital management | - | - | -246.90K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Y-intercept (hong kong) | 250.85K | 0.01% | 250.85K | $290.98K |
| Marshall wace, llp | 137.94K | 0.00% | 137.94K | $160.01K |
| Hrt financial lp | 31.43K | 0.00% | 31.43K | $36.00K |
| Point72 asia (singapore) pte. | 21.34K | 0.00% | 21.34K | $24.75K |
| Drw securities | 11.02K | 0.00% | 11.02K | $12.78K |
Sold Out
| Holder | Change |
|---|---|
| True wealth design | -35.00 |
| Capital performance advisors llp | -52.00 |
| Russell investments group | -278.00 |
| Coldstream capital management | -311.00 |
| Rise advisors | -373.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2025 | 72 | -13.25% | 37,610,957 | -6.52% | 62 | 1.41% | 31 | 19.23% | 24 | -29.41% |
| Mar 31, 2025 | 5 | -93.83% | 16,490,041 | -61.19% | 27 | 0.54% | 1 | -97.50% | 2 | -90.00% |
| Dec 31, 2024 | 81 | 5.19% | 42,494,401 | -2.55% | 70 | 1.34% | 40 | 17.65% | 20 | -4.76% |
| Sep 30, 2024 | 77 | -10.47% | 43,605,266 | 0.06% | 72 | 1.37% | 34 | -24.44% | 21 | 10.53% |
| Jun 30, 2024 | 86 | 2.38% | 43,581,297 | 0.50% | 72 | 1.30% | 45 | -8.16% | 19 | -13.64% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Franklin Biotechnology Discv A(acc)USD | 1.48M | 2.44% | - |
| Fidelity Select Health Care | 1.14M | 1.88% | - |
| Vanguard Total Stock Mkt Idx Inv | 1.12M | 1.85% | -24.52K |
| iShares Russell 2000 ETF | 971.80K | 1.60% | - |
| Franklin Biotechnology Discovery A | 826.40K | 1.36% | - |
| Franklin US Small Cap Growth Equity | 771.94K | 1.27% | 3.97K |
| Franklin Small Cap Growth SMA | 771.94K | 1.27% | 771.94K |
| Franklin Small Cap Growth Adv | 708.38K | 1.17% | -59.59K |
| Fidelity Advisor Health Care I | 700.00K | 1.16% | - |
| Fidelity Small Cap Index | 408.40K | 0.67% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jan 21, 2025 | Zuga Matt | CFO & Chief Business Officer | Sell | $6.99K |
| Jan 23, 2025 | Zuga Matt | CFO & Chief Business Officer | Sell | $49.63K |
| Jan 21, 2025 | OConnell Daniel Joseph | Chief Executive Officer | Sell | $20.10K |
| Jan 21, 2025 | Meisner Derek M | Chief Legal Officer & Corp Sec | Sell | $5.43K |
| Jan 21, 2025 | Barton Russell | Chief Operating Officer | Sell | $4.69K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q2 | - | - |
| 2025 Q1 | - | 11 |
| 2024 Q4 | - | - |
| 2024 Q2 | - | - |
| 2024 Q1 | - | 5 |
ABOS Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools